| | | Single nucleotide variant (missense variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | | Duplication (frameshift variant) | Acute myeloid leukemia +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Deafness-lymphedema-leukemia syndrome +7 more | GConflicting classifications of pathogenicity |
| | | Duplication (frameshift variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant) | Deafness-lymphedema-leukemia syndrome +2 more | |
| | | Duplication (frameshift variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Deletion (splice acceptor variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant) | Deafness-lymphedema-leukemia syndrome +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Deafness-lymphedema-leukemia syndrome +5 more | |
| | | Single nucleotide variant (missense variant) | GATA2 deficiency with susceptibility to MDS/AML +2 more | |
| | | Single nucleotide variant (missense variant) | Deafness-lymphedema-leukemia syndrome +3 more | |
| | | Single nucleotide variant (missense variant) | Deafness-lymphedema-leukemia syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Microsatellite (frameshift variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant) | GATA2 deficiency with susceptibility to MDS/AML +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Deafness-lymphedema-leukemia syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (intron variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (splice donor variant) | GATA2 deficiency with susceptibility to MDS/AML +2 more | GPathogenic/Likely pathogenic |
| | | Deletion (frameshift variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Duplication (frameshift variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (nonsense) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Deletion (inframe_deletion) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant) | GATA2 deficiency with susceptibility to MDS/AML +2 more | |
| | | Single nucleotide variant (nonsense) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Deletion (frameshift variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant) | Monocytopenia with susceptibility to infections +2 more | |
| | | Single nucleotide variant (missense variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Deafness-lymphedema-leukemia syndrome +5 more | GConflicting classifications of pathogenicity |
| | | Deletion (frameshift variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant) | Deafness-lymphedema-leukemia syndrome +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Monocytopenia with susceptibility to infections +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Deletion (frameshift variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Duplication (frameshift variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Deletion (frameshift variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Deletion (inframe_deletion) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Deletion (inframe_deletion) | Deafness-lymphedema-leukemia syndrome +1 more | |
| | | Single nucleotide variant (missense variant) | GATA2 deficiency with susceptibility to MDS/AML +2 more | |
| | | Single nucleotide variant (nonsense) | Monocytopenia with susceptibility to infections +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Inborn genetic diseases +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Deafness-lymphedema-leukemia syndrome +1 more | |
| | | Single nucleotide variant (missense variant) | Monocytopenia with susceptibility to infections +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Deafness-lymphedema-leukemia syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant) | Deafness-lymphedema-leukemia syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Microsatellite (inframe_deletion) | not provided +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant) | Deafness-lymphedema-leukemia syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Deafness-lymphedema-leukemia syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Deletion (inframe_deletion) | Deafness-lymphedema-leukemia syndrome +1 more | |
| | | Single nucleotide variant (missense variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant) | Deafness-lymphedema-leukemia syndrome +3 more | |
| | | Single nucleotide variant (missense variant) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Deletion (frameshift variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Leukemia, acute myeloid, susceptibility to +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Deafness-lymphedema-leukemia syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Deletion (frameshift variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (intron variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Deafness-lymphedema-leukemia syndrome +1 more | GPathogenic/Likely pathogenic |
| | | Deletion (frameshift variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Duplication (intron variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Duplication (frameshift variant +1 more) | Deafness-lymphedema-leukemia syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Deletion (splice acceptor variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Insertion (frameshift variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +4 more | |
| | | Microsatellite (inframe_insertion +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Deletion (frameshift variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Deletion (intron variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Duplication (frameshift variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Deletion (intron variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Duplication (frameshift variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Deletion (intron variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Insertion (frameshift variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Microsatellite (inframe_deletion +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Duplication (frameshift variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Deletion (frameshift variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Monocytopenia with susceptibility to infections +6 more | |
| | | Deletion (frameshift variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Deletion (frameshift variant +1 more) | Deafness-lymphedema-leukemia syndrome +2 more | GPathogenic/Likely pathogenic |
| | | Insertion (frameshift variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Deletion (frameshift variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (intron variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (intron variant +1 more) | Deafness-lymphedema-leukemia syndrome +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (intron variant +1 more) | GATA2 deficiency with susceptibility to MDS/AML +1 more | |
| | | Single nucleotide variant (intron variant +1 more) | Deafness-lymphedema-leukemia syndrome +2 more | |
| | | Duplication (intron variant) | Deafness-lymphedema-leukemia syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Deafness-lymphedema-leukemia syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | GATA2 deficiency with susceptibility to MDS/AML +4 more | GPathogenic/Likely pathogenic |